HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Rong Ou Selected Research

Yu-Rong Ou Research Topics

Disease

4Hepatocellular Carcinoma (Hepatoma)
01/2019 - 02/2016
4Neoplasms (Cancer)
01/2019 - 02/2016
2Carcinoma (Carcinomatosis)
01/2019 - 07/2016
2Fibrosis (Cirrhosis)
07/2016 - 07/2015
1Cysts
01/2019
1Adenocarcinoma
01/2019
1Neoplasm Metastasis (Metastasis)
06/2017
1Embolism (Embolus)
07/2016
1Hepatitis
07/2016
1Lymphatic Metastasis
07/2016
1Inflammation (Inflammations)
07/2016
1Carcinogenesis
07/2016
1Body Weight (Weight, Body)
07/2015
1Hypertension (High Blood Pressure)
07/2015

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
07/2016 - 07/2015
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 02/2016
1CrizotinibIBA
01/2019
1CateninsIBA
06/2017
1Messenger RNA (mRNA)IBA
07/2016
1Interleukin-33IBA
07/2016
1CytokinesIBA
07/2016
1Interleukin-1 (Interleukin 1)IBA
07/2016
1Pharmaceutical PreparationsIBA
02/2016
1Connexin 26IBA
02/2016
1ConnexinsIBA
02/2016
1Desoxycorticosterone Acetate (DOCA)FDA Link
07/2015
1Grape Seed ProanthocyanidinsIBA
07/2015
1Acetates (Acetic Acid Esters)FDA Link
07/2015
1Antihypertensive Agents (Antihypertensives)IBA
07/2015
1Desoxycorticosterone (Deoxycorticosterone)IBA
07/2015
1Hydroxyproline (4 Hydroxyproline)IBA
07/2015
1Malondialdehyde (Propanedial)IBA
07/2015
1SaltsIBA
07/2015
1salicylhydroxamic acid (SHAM)IBA
07/2015

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2019 - 01/2019
1Aftercare (After-Treatment)
01/2019
1Therapeutics
06/2017